tiopronin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 60219-2009
  • Package NDC 60219-2009-9
  • Application number ANDA216278
  • SPL ID 98b9196d-4cc8-4ffe-8a45-8bced8f4284f
  • SPL set ID ce5b1f97-5b3c-40b6-b1c4-1d36025be1b8
  • UNII C5W04GO61S
  • RxCUI 2178079

What the source publishes

Labeler
Amneal Pharmaceuticals NY LLC
Active ingredients
tiopronin
Form
TABLET, DELAYED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:60219-2009_98b9196d-4cc8-4ffe-8a45-8bced8f4284f
{
  "name": "tiopronin",
  "splId": "98b9196d-4cc8-4ffe-8a45-8bced8f4284f",
  "labels": [
    {
      "setId": "ce5b1f97-5b3c-40b6-b1c4-1d36025be1b8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce5b1f97-5b3c-40b6-b1c4-1d36025be1b8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ce5b1f97-5b3c-40b6-b1c4-1d36025be1b8"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Amneal Pharmaceuticals NY LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "90 TABLET, DELAYED RELEASE in 1 BOTTLE (60219-2009-9)",
      "package_ndc": "60219-2009-9",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250102"
    }
  ],
  "productId": "60219-2009_98b9196d-4cc8-4ffe-8a45-8bced8f4284f",
  "useDomain": "unknown",
  "dosageForm": "TABLET, DELAYED RELEASE",
  "productNdc": "60219-2009",
  "deaSchedule": null,
  "genericName": "tiopronin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TIOPRONIN",
      "strength": "300 mg/1"
    }
  ],
  "applicationNumber": "ANDA216278",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250102",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175549",
      "M0289359",
      "N0000175898"
    ],
    "upc": [
      "0360219200999"
    ],
    "unii": [
      "C5W04GO61S"
    ],
    "rxcui": [
      "2178079"
    ],
    "spl_set_id": [
      "ce5b1f97-5b3c-40b6-b1c4-1d36025be1b8"
    ],
    "pharm_class_cs": [
      "N-substituted Glycines [CS]"
    ],
    "pharm_class_epc": [
      "Reducing and Complexing Thiol [EPC]"
    ],
    "pharm_class_moa": [
      "Cystine Disulfide Reduction [MoA]"
    ],
    "manufacturer_name": [
      "Amneal Pharmaceuticals NY LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:60219-2009_98b9196d-4cc8-4ffe-8a45-8bced8f4284f"